Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Am Coll Cardiol. 2020 Jan 21;75(2):148–158. doi: 10.1016/j.jacc.2019.10.058

TABLE 5.

Crude Incidence and Adjusted Risk for VTE bv Incident HF Subtype (ARIC, 2005 to 2015)

No HF (n = 6,583) Any HF (n = 1,005) HFpEF (n = 278) HFrEF (n = 275) Undetermined HF Type (n = 452)
Number of VTE events 199 63 21 19 23
 Person-years 65,451 2,895 908 778 1,208
 Incidence rate (95% CI)* 3.04 (2.64–3.49) 21.8 (16.9–27.6) 23.1 (14.7–34.7) 24.4 (15.2–37.4) 19.0 (12.4–28.1)
 Hazard ratio (95% CI) 1.00 (reference) 5.15 (3.80–6.98) 4.71 (2.94–7.52) 5.53 (3.42–8.94) 4.09 (2.60–6.44)
 Race interaction, p value 0.36 0.49 0.86 0.55
Number of PE events 135 36 12 7 17
 Hazard ratio (95% CI) 1.00 (reference) 4.41 (2.98–6.54) 4.09 (2.22–7.55) 3.12 (1.45–6.74) 4.55 (2.67–7.75)
Number of DVT events 64 27 9 12 6
 Hazard ratio (95% CI) 1.00 (reference) 6.66 (4.11–10.81) 5.91 (2.84–12.3) 10.1 (5.34–19.0) 3.21 (1.34–7.66)
Number of unprovoked VTE events 87 26 8 7 11
 Hazard ratio (95% CI) 1.00 (reference) 4.77 (2.99–7.62) 4.01 (1.89–8.50) 4.66 (2.13–10.2) 4.59 (2.37–8.90)
Number of provoked VTE events 112 37 13 12 12
 Hazard ratio (95% CI) 1.00 (reference) 5.53 (3.71–8.25) 5.39 (2.95–9.82) 6.44 (3.49–11.9) 3.74 (2.00–7.00)

Unadjusted incidence rate is per 1,000 person-years.

*

Final model adjusted for 1996 to 1998 values of age (continuous), race, sex, body mass index (continuous), education (more than high school vs. not), hypertension, and aspirin use.

Abbreviations as in Tables 1, 2, and 4.